The latest market report published by Credence Research, Inc. “Global Sentinel Node Biopsy Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028. The global Sentinel Node Biopsy market has witnessed steady growth in recent years and is expected to continue growing at a CAGR of 5.20% between 2023 and 2030. The market was valued at USD 0.42 billion in 2022 and is expected to reach USD 0.59890711 billion in 2030.
The expected growth of the Sentinel Node Biopsy market is attributable to the continuous advancements in medical technology and the rising prevalence of cancer worldwide. At the same time, the sector faces challenges such as technical issues and false negative results, and the high cost of sentinel node biopsy, including equipment, imaging agents, and surgical procedures.
The market, segmented by type, application, and region, shows that Tissue Markers, gamma probes, and breast localization wire are the primary type segments, with Hospitals & Clinics leading the applications. The Asia-pacific region is leading market growth.
Despite facing significant challenges, including technical issues and false negative results, high costs of sentinel node biopsy equipment, imaging agents, and surgical procedures, the market also presents growth opportunities. These opportunities include the rising awareness about cancer and the importance of early detection, as well as the development of innovative technologies and techniques.
Key players in the competitive global Sentinel Node Biopsy market include Devicor Medical Products, Inc., C. R. Bard, Inc., INTRAMEDICAL IMAGING LLC, Hilfe Engineering Corporation, Surgical Eye, KUB Technologies, Inc., and Navidea Biopharmaceuticals, Inc. These companies stay ahead through continuous innovation, application expansion, and strategic mergers and acquisitions.
U.K. Sentinel Node Biopsy Market Drivers are varied and complex. One of the primary drivers is an increasing demand for minimally invasive procedures, which have become increasingly popular due to their reduced recovery times and decreased risk of complications compared to traditional surgical methods. Additionally, there has been a growing awareness among patients regarding the importance of early detection and treatment of cancer, leading to increased adoption rates for sentinel node biopsy procedures in particular. Technological advancements in imaging techniques such as ultrasound-guided biopsy have also contributed significantly to market growth by enabling more accurate diagnoses with smaller incisions. Moreover, favorable government initiatives promoting early diagnosis and screening programs have further fuelled this market’s expansion by providing incentives for healthcare providers who offer these services.
Why to Buy This Report-
- The report provides a qualitative as well as quantitative analysis of the global Sentinel Node Biopsy Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.
- The report includes information on the competitive landscape, such as how the market’s top competitors operate at the global, regional, and country levels.
- In-depth analysis of the global market segmentation on the Route of Administration and Application
- Major nations in each region with their import/export statistics
- The global Sentinel Node Biopsy Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.
Browse Full Report: https://www.credenceresearch.com/report/sentinel-node-biopsy-market